Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

Go back to Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026
(NASDAQ: KNSA) Delayed: 78.08 --0 (-0%)
Previous Close $78.08    52 Week High
Open $78.08    52 Week Low
Day High $78.08    P/E N/A 
Day Low $78.08    EPS
Volume 464